Dr. Reddy's Laboratories
RDY
#1703
Rank
ยฃ8.85 B
Marketcap
ยฃ10.59
Share price
0.07%
Change (1 day)
-4.66%
Change (1 year)

Dr. Reddy's Laboratories (RDY) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ1.51 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's total liabilities are ยฃ1.51 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Dr. Reddy's Laboratories - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-03-31ยฃ1.41 B38.97%
2024-03-31ยฃ1.01 B13.35%
2023-03-31ยฃ0.89 B-12.62%
2022-03-31ยฃ1.02 B11.92%
2021-03-31ยฃ0.91 B10.81%
2020-03-31ยฃ0.82 B-12.32%
2019-03-31ยฃ0.94 B-13.1%
2018-03-31ยฃ1.08 B-7.86%
2017-03-31ยฃ1.17 B41.29%
2016-03-31ยฃ0.83 B-7.74%
2015-03-31ยฃ0.90 B13.71%
2014-03-31ยฃ0.79 B-5.81%
2013-03-31ยฃ0.84 B10.58%
2012-03-31ยฃ0.76 B10.91%
2011-03-31ยฃ0.68 B25.36%
2010-03-31ยฃ0.54 B-3.95%
2009-03-31ยฃ0.57 B20.11%
2008-03-31ยฃ0.47 B-9.31%
2007-03-31ยฃ0.52 B-12.83%
2006-03-31ยฃ0.60 B491.4%
2005-03-31ยฃ0.10 B46.48%
2004-03-31ยฃ69.44 M22.57%
2003-03-31ยฃ56.66 M12.43%
2002-03-31ยฃ50.39 M-49.62%
2001-03-31ยฃ0.10 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
ยฃ86.61 B 5,609.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ24.42 B 1,509.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
ยฃ45.90 B 2,926.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
ยฃ46.84 B 2,987.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
ยฃ49.45 B 3,160.23%๐Ÿ‡ซ๐Ÿ‡ท France